Reading time is 1 mins


While many countries have begun to normalize against the corona virus, which has killed more than 6 million people worldwide, the Omicron XE variant has recently been detected in many countries, especially the United Kingdom and Thailand.

New variants of the outbreak of the corona virus, which has been worrying the world since the last weeks of 2019, continue to appear.

It was announced that cases of Omicron XE, a subtype of the Omicron variant of the corona virus, continue to increase in the UK. While experts note that it is not yet known how contagious this variant is, it is known that this mutation is caused by Omicron.1 and BA. was quoted that it consists of a decoupling of 2 extensions.

The variant has been growing rapidly recently, while the British Health Safety Agency’s data showed that the number of cases has increased by 9.8 percent.

But it was noted that this case ratio has yet coincided with a small part of the total cases, while it was emphasized that among the subspecies of the Omicron variant, there are XD, XF and XE. Deciphered, the Omicron variant is not yet included in the total number of deciphered cases. While it was announced that XD was seen in some European countries, it was also stated that XE was the biggest concern. Scientists have found that the Omicron XE variant is similar to the original Omicron (BA.1) mutated with Omicron (BA.2) he also noted that it arose from the combination of its variants.


On the other hand, a statement was also received from the World Health Organization, which is an official within the United Nations, regarding the mutation.

While the World Health Organization explained that Omicron XE may be the most infectious variant that has emerged so far, “According to early results, this variant is can multiply 10 percent faster than 2. But it is necessary to increase the work to confirm this yet,” it said.


Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.


Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.


Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.


Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me